[Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?].
Folwaczny
C
C
Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität, München.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004926:Escherichia coli; D006801:Humans; D019804:Mesalamine / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D019936:Probiotics / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine